Behçet's disease epidemiology and demographics
|
Behçet's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Behçet's disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Behçet's disease epidemiology and demographics |
|
Blogs on Behçet's disease epidemiology and demographics</smal |
|
Risk calculators and risk factors for Behçet's disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]
Overview
Epidemiology and Demographics
Prevalence
- The prevalence of behcet disease is approximately 80 to 370 per 100,000 individuals in Turkey[1][2]
- The prevalence of behcet disease is approximately 13.5 to 20 per 100,000 individuals in Iran, Japan, Korea, China and Saudi Arabia[1]
- The prevalence of behcet disease is approximately 7.1 per 100,000 individuals in Paris, France[3]
- The prevalence of behcet disease is approximately 2.4 per 100,000 individuals in European ancestry[3]
- The prevalence of behcet disease is approximately 34.6 per 100,000 individuals in North African ancestry[3]
- The prevalence of behcet disease is approximately 17.5 per 100,000 individuals in Asian ancestry[3]
- The prevalence of behcet disease is approximately 0.12 to 7.5 per 100,000 individuals in the United States[4]
Age
- Behcet disease commonly affects young adults 20 to 40 years of age[5]
Race
- Behcet disease usually affects individuals of the Turkish, Asian, and Middle Eastern populations. Middle Eastern and Asian individuals are more likely to develop Behcet disease due to theincreased incidence of skin pathergy and HLA-B51 antigen.
Gender
- Males are more commonly affected by Behcet disease than females. The male to female ratio ranges from approximately 11 to 1 to 2 to 1.
Region
- The majority of behcet disease cases are reported along the ancient silk road ( from eastern Asia to the Mediterranean)[1]
- Behcet disease is most common in Turkey.
References
- ↑ 1.0 1.1 1.2 Sakane T, Takeno M, Suzuki N, Inaba G (October 1999). "Behçet's disease". N. Engl. J. Med. 341 (17): 1284–91. doi:10.1056/NEJM199910213411707. PMID 10528040.
- ↑ Sarica-Kucukoglu R, Akdag-Kose A, KayabalI M, Yazganoglu KD, Disci R, Erzengin D; et al. (2006). "Vascular involvement in Behçet's disease: a retrospective analysis of 2319 cases". Int J Dermatol. 45 (8): 919–21. doi:10.1111/j.1365-4632.2006.02832.x. PMID 16911374.
- ↑ 3.0 3.1 3.2 3.3 Mahr A, Belarbi L, Wechsler B, Jeanneret D, Dhote R, Fain O, Lhote F, Ramanoelina J, Coste J, Guillevin L (December 2008). "Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration". Arthritis Rheum. 58 (12): 3951–9. doi:10.1002/art.24149. PMID 19035493.
- ↑ Calamia KT, Wilson FC, Icen M, Crowson CS, Gabriel SE, Kremers HM (May 2009). "Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study". Arthritis Rheum. 61 (5): 600–4. doi:10.1002/art.24423. PMC 3024036. PMID 19405011.
- ↑ Sakane T, Takeno M, Suzuki N, Inaba G (October 1999). "Behçet's disease". N. Engl. J. Med. 341 (17): 1284–91. doi:10.1056/NEJM199910213411707. PMID 10528040.